Ferrandina G, Scambia G, Benedetti Panici P, Almadori G, Paludetti G, Cadoni G, Distefano M, Maurizi M, Mancuso S
Department of Obstetrics and Gynecology, Catholic University, L.go A. Gemelli, Rome, Italy.
Cancer Lett. 1992 Dec 24;67(2-3):133-8. doi: 10.1016/0304-3835(92)90136-j.
Using an immunoradiometric assay, Cathepsin D (Cath D) levels were measured in the cytosol of 23 normal and 39 neoplastic human laryngeal tissues. Scattered Cath D levels (from 2.2 to 17.8 pM/mg protein; median = 7.6) were found in normal mucosa specimens. Cath D concentrations range from 2.0 to 29.3 pM/mg protein (median = 8.5) in laryngeal tumors. When a comparison between Cath D levels in normal and neoplastic tissue specimens from the same patient was done, Cath D levels were significantly higher in laryngeal cancers than in their normal counterparts (P = 0.03). No correlation with clinico-pathological parameters and steroid hormone and epidermal growth factor receptor status was found. Further studies should investigate whether the production of Cath D by laryngeal tumors could have a clinical relevance for this neoplasia.
采用免疫放射分析方法,测定了23例正常人类喉组织和39例肿瘤性人类喉组织细胞质中的组织蛋白酶D(Cath D)水平。在正常黏膜标本中发现Cath D水平呈散在分布(2.2至17.8 pM/毫克蛋白;中位数 = 7.6)。喉肿瘤中Cath D浓度范围为2.0至29.3 pM/毫克蛋白(中位数 = 8.5)。当对同一患者的正常组织标本和肿瘤组织标本中的Cath D水平进行比较时,喉癌中的Cath D水平显著高于其正常对应组织(P = 0.03)。未发现与临床病理参数、类固醇激素及表皮生长因子受体状态存在相关性。进一步的研究应调查喉肿瘤产生Cath D是否可能与该肿瘤具有临床相关性。